Response to Majeranowski

Affiliations

¹ Pediatric Nephrology Department, Hopital Robert-Debré, APHP, Paris, France. claire.dossier@aphp.fr.
² Pediatric Nephrology Department, Hopital Robert-Debré, APHP, Paris, France.

Comment

Claire Dossier et al. Pediatr Nephrol. 2021 Jun.

. 2021 Jun;36(6):1653.

doi: 10.1007/s00467-021-04982-4. Epub 2021 Mar 10.

¹ Pediatric Nephrology Department, Hopital Robert-Debré, APHP, Paris, France. claire.dossier@aphp.fr.
² Pediatric Nephrology Department, Hopital Robert-Debré, APHP, Paris, France.

No abstract available

Comment on

A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome.
Dossier C, Prim B, Moreau C, Kwon T, Maisin A, Nathanson S, De Gennes C, Barsotti K, Bourrassi A, Hogan J, Deschênes G. Dossier C, et al. Pediatr Nephrol. 2021 May;36(5):1175-1182. doi: 10.1007/s00467-020-04811-0. Epub 2020 Oct 28. Pediatr Nephrol. 2021. PMID: 33118048 Free PMC article.
Regarding: A global anti-B cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome.
Majeranowski A, Okrój M. Majeranowski A, et al. Pediatr Nephrol. 2021 Jun;36(6):1651-1652. doi: 10.1007/s00467-021-04981-5. Epub 2021 Feb 18. Pediatr Nephrol. 2021. PMID: 33604726 No abstract available.

1. Kamei K, Ogura M, Sato M, Ito S, Ishikura K (2018) Infusion reactions associated with rituximab treatment for childhood-onset complicated nephrotic syndrome. Pediatr Nephrol 33:1013–1018 - DOI
1. Bonanni A, Calatroni M, D'Alessandro M, Signa S, Bertelli E, Cioni M, Di Marco E, Biassoni R, Caridi G, Ingrasciotta G, Bertelli R, Di Donato A, Bruschi M, Canepa A, Piaggio G, Ravani P, Ghiggeri GM (2018) Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome. Br J Clin Pharmacol 84:1238–1249 - DOI
1. Ravani P, Bonanni A, Ghiggeri GM (2017) Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol. BMJ Open 7:e013319 - DOI